Medicine and Dentistry
Heart Surgery
100%
Diabetes Mellitus
85%
Elective Surgery
69%
Liraglutide
61%
Placebo
59%
Perioperative Period
52%
Acute Kidney Injury
52%
Sodium Glucose Cotransporter 2
52%
Hyperglycemia
41%
Intensive Care
39%
COVID-19
39%
Cohort Analysis
38%
Glycemic Control
36%
Postoperative Complication
36%
Empagliflozin
31%
Nursing and Health Professions
Perioperative
47%
Heart Surgery
39%
Diabetes Mellitus
31%
Elective Surgery
27%
Cohort Analysis
26%
Acute Kidney Failure
26%
Pilot Study
26%
Sodium Glucose Cotransporter 2
26%
Empagliflozin
18%
Patient with Diabetes
16%
Perioperative Period
16%
Meta Analysis
15%
Non Insulin Dependent Diabetes Mellitus
13%
Cross-Sectional Study
13%
Treatment Outcome
13%
Keyphrases
Elective Surgery
39%
Acute Kidney Injury
30%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
28%
Cardiac Surgery Patients
28%
Empagliflozin
26%
Liraglutide
26%
Sodium-glucose Transporter 2
26%
Inpatient Surgery
20%
After Surgery
20%
Failure to Rescue
19%
Odds Ratio
17%
Glucagon-like
17%
Receptor Agonist
17%
A1 Receptor
17%
Low-middle Income Countries
15%
